Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...
Meghan Markle's New Brand Logo Is Full of Hidden Meanings. Here's What They Really Represent
At the end of the book, published in January 2023, Prince Harry reflected on a visit from a hummingbird to his Montecito home after the death of his grandmother, Queen Elizabeth, noting how the bird ...